Innoviva Specialty Therapeutics, Inc.
Patricia Drake is an accomplished executive with extensive experience in commercial leadership within the pharmaceutical industry. Currently serving as Chief Commercial Officer at Innoviva Specialty Therapeutics, Inc., Patricia has held prominent roles including Chief Commercial Officer at Trevena, Inc. and Sesen Bio. Prior experience includes holding the position of CEO and Managing Director at MSD Finland Oy and serving in various capacities at Merck, including leadership in the Global Human Health Commercial Strategy Office and U.S. Market Operations. Additionally, Patricia has experience as Vice President of Primary Care Sales in Canada, showcasing a versatile background in strategic commercial operations.
This person is not in any teams
This person is not in any offices
Innoviva Specialty Therapeutics, Inc.
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc., is a biopharmaceutical company developing and delivering innovative therapies in critical care and infectious disease. Our approved treatments are indicated for use in life-threatening circumstances for seriously ill patients, and our investigational therapies are in development for patients fighting drug-resistant pathogens. Growing antimicrobial resistance to existing therapies represents an urgent threat to global public health, and is directly related to significant mortality rates and longer, more expensive hospital stays. We are proud to work with physicians, nurses, hospital pharmacists and administrators, and all who devote their time to caring for patients.